Approval · Notice of Compliance 3072 · 1998
VIRAMUNE: Notice of Compliance 3072
Issued September 4, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
Issued with conditions (NOC/c): the company must confirm the benefit in further studies.
- Notice number
- 3072
- Date
- September 4, 1998
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antiretroviral
- With conditions
- Yes (NOC/c)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VIRAMUNE | 02238748 | Cancelled Post Market |
Medicinal ingredients
- NEVIRAPINE 200 MG per TAB